Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2021 Jan 10;87(4):525–532. doi: 10.1007/s00280-020-04224-8

Table 5.

Pharmacokinetic Parameters of Intravenous Fenretinide (4-HPR)

905 mg/m2/d (n=3) 1131 mg/m2/d (n=3)
Median Range Median Range
V (L) 168.5 74.4–255.9 193.1 122.5–420.5
CL (L/h) 6.1 4.3–11.0 8.9 5.2–10.2
t1/2 (h) 16.2 11.9–19.0 16.3 15.0–28.5
AUC0–192 (μg·h/mL) 1279 897–1532 1297 809–1859
Cmax (μg/mL) 12.2 8.1–14.5 12.3 7.8–18.8
Css (μg/mL) 10.5 7.2–12.1 10.4 7.0–15.0